• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右美沙芬和咖啡因作为同时测定儿童异喹胍氧化和N-乙酰化表型的探针。

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.

作者信息

Evans W E, Relling M V, Petros W P, Meyer W H, Mirro J, Crom W R

机构信息

Pharmacokinetics and Pharmacodynamics Section, St. Jude Children's Research Hospital, Memphis, TN 38101-0318.

出版信息

Clin Pharmacol Ther. 1989 May;45(5):568-73. doi: 10.1038/clpt.1989.74.

DOI:10.1038/clpt.1989.74
PMID:2721111
Abstract

The feasibility and reliability of simultaneously determining debrisoquin oxidation and N-acetylation phenotypes was assessed in children with use of two innocuous substrate probes given by mouth, 30 mg dextromethorphan (Pertussin ES) and 25 to 46 mg caffeine (Coca-Cola beverage). Twenty-six children and adolescents (aged 3 to 21 years) were studied three times, once with each substrate given alone and once with the two substrates given together. Urine was collected for 4 hours, and the molar urinary metabolic ratios for dextromethorphan:dextrorphan and for two caffeine metabolites (AFMU:1X) were determined by HPLC ultraviolet assays. The urinary metabolic ratios for both substrates were not significantly different when the substrates were given alone compared with when they were given together. There also was no difference in either the oxidation or acetylation phenotype assignments when the two substrates were given alone and when they were given together. No adverse effects were observed. We conclude that dextromethorphan and caffeine can be given together to simultaneously determine oxidation and acetylation phenotypes and can thereby provide an innocuous, noninvasive method for the assessment of polymorphic drug metabolism in various pediatric populations.

摘要

通过口服两种无害底物探针(30毫克右美沙芬(右美沙芬糖浆)和25至46毫克咖啡因(可口可乐饮料)),评估了在儿童中同时测定异喹胍氧化和N - 乙酰化表型的可行性和可靠性。对26名儿童和青少年(年龄3至21岁)进行了三次研究,一次仅给予每种底物,一次将两种底物一起给予。收集4小时尿液,通过高效液相色谱紫外测定法测定右美沙芬:右啡烷的摩尔尿代谢比以及两种咖啡因代谢物(1 - 甲基黄嘌呤:5 - 乙酰氨基 - 6 - 甲氧基 - 2 - 甲基嘌呤)的摩尔尿代谢比。与一起给予底物时相比,单独给予底物时两种底物的尿代谢比无显著差异。单独给予两种底物和一起给予两种底物时,氧化或乙酰化表型的判定也没有差异。未观察到不良反应。我们得出结论,右美沙芬和咖啡因可以一起给予以同时测定氧化和乙酰化表型,从而为评估不同儿科人群中的多态性药物代谢提供一种无害、非侵入性的方法。

相似文献

1
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.右美沙芬和咖啡因作为同时测定儿童异喹胍氧化和N-乙酰化表型的探针。
Clin Pharmacol Ther. 1989 May;45(5):568-73. doi: 10.1038/clpt.1989.74.
2
Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.
Clin Pharmacol Ther. 1989 Mar;45(3):328-33. doi: 10.1038/clpt.1989.36.
3
Pharmacogenetics of dextromethorphan O-demethylation in man.
Xenobiotica. 1986 May;16(5):421-33. doi: 10.3109/00498258609050249.
4
Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.多态性右美沙芬代谢:氧化O-去甲基化与异喹胍羟基化的共分离。
Clin Pharmacol Ther. 1985 Dec;38(6):618-24. doi: 10.1038/clpt.1985.235.
5
The influence of insulin-dependent diabetes on the metabolism of caffeine and the expression of the debrisoquin oxidation phenotype.胰岛素依赖型糖尿病对咖啡因代谢及异喹胍氧化表型表达的影响。
Clin Pharmacol Ther. 1988 Oct;44(4):408-17. doi: 10.1038/clpt.1988.173.
6
In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
Biochem Pharmacol. 1988 Aug 15;37(16):3155-60. doi: 10.1016/0006-2952(88)90314-0.
7
Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism.
Lancet. 1984 Dec 15;2(8416):1393. doi: 10.1016/s0140-6736(84)92081-6.
8
Determination of dextromethorphan metabolizer phenotype in healthy volunteers.
Eur J Clin Pharmacol. 1989;36(3):315-8. doi: 10.1007/BF00558166.
9
Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.右美沙芬:人体中O-去甲基化和双去甲基化代谢产物的多态性血清模式。
Br J Clin Pharmacol. 1989 Feb;27(2):223-7. doi: 10.1111/j.1365-2125.1989.tb05354.x.
10
Polymorphism of dextromethorphan oxidation in a French population.法国人群中右美沙芬氧化的多态性。
Br J Clin Pharmacol. 1987 Nov;24(5):676-9. doi: 10.1111/j.1365-2125.1987.tb03230.x.

引用本文的文献

1
Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic acid (SSDA) as a Urinary Biomarker of Cytochrome P450 2D6 (CYP2D6) Activity.3,4-裂环茄啶-3,4-二酸(SSDA)作为细胞色素P450 2D6(CYP2D6)活性的尿液生物标志物的分离与鉴定
Drug Metab Dispos. 2022 Jul 25;50(10):1342-51. doi: 10.1124/dmd.122.000957.
2
Ontogeny of Pediatric Pharmacogenetics: Celebrating the Past and Vision for the Future.儿科药物遗传学的个体发生:回顾过去与展望未来
J Pediatr Pharmacol Ther. 2022;27(1):4-11. doi: 10.5863/1551-6776-27.1.4. Epub 2021 Dec 22.
3
Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.
儿童非酒精性脂肪性肝病患者的对乙酰氨基酚药代动力学。
J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):198-202. doi: 10.1097/MPG.0b013e3181f9b3a0.
4
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.人类细胞色素P450 2D6的多态性及其临床意义:第一部分。
Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000.
5
Clinical pharmacokinetics of atomoxetine.托莫西汀的临床药代动力学
Clin Pharmacokinet. 2005;44(6):571-90. doi: 10.2165/00003088-200544060-00002.
6
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.细胞色素P450 2D6:药理学、遗传学、生物化学概述及最新进展
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):23-37. doi: 10.1007/s00210-003-0832-2. Epub 2003 Nov 15.
7
Influence of hydroxychloroquine on the bioavailability of oral metoprolol.羟氯喹对口服美托洛尔生物利用度的影响。
Br J Clin Pharmacol. 2000 Jun;49(6):549-54. doi: 10.1046/j.1365-2125.2000.00197.x.
8
Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS.对乙酰氨基酚在HIV阳性患者和艾滋病患者体内的葡萄糖醛酸化和硫酸化作用。
Br J Clin Pharmacol. 1999 Dec;48(6):811-8. doi: 10.1046/j.1365-2125.1999.00084.x.
9
Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan.尿液分析中去结合步骤的省略以及右美沙芬对CYP2D6表型分析结果无影响。
Eur J Drug Metab Pharmacokinet. 1998 Jan-Mar;23(1):1-5. doi: 10.1007/BF03189819.
10
Acetylation as an indicator of risk.乙酰化作为风险指标。
Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):763-6. doi: 10.1289/ehp.97105s4763.